Boston Scientific Corporation
Boston Scientific Corporation’s EPS Growth at a glance
Boston Scientific Corporation reports eps growth of 16.6% for Dec 2024. The prior period recorded 140.8% (Dec 2023). Year over year the metric moved −124.1 pts (−88.2%). The rolling three-period average stands at 40.7%. Data last refreshed Dec 18, 2025, 5:29 AM.
Latest reading
16.6% · Dec 2024
YoY movement
−124.1 pts (−88.2%)
Rolling average
40.7%
Current EPS Growth
16.6%
−124.1 pts
−88.2%
Rolling average
40.7%
Latest Value
16.6%
Dec 2024
YoY Change
−124.1 pts
Absolute
YoY Change %
−88.2%
Rate of change
3-Period Avg
40.7%
Smoothed
Narrative signal
Boston Scientific Corporation’s eps growth stands at 16.6% for Dec 2024. Year-over-year, the metric shifted by −124.1 pts, translating into a −88.2% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How eps growth shapes Boston Scientific Corporation's story
As of Dec 2024, Boston Scientific Corporation reports eps growth of 16.6%. Review EPS trajectory, compounding pace, and earnings momentum supported by trailing annual filings.
Understanding EPS momentum
Sustained positive EPS growth underpins long-term shareholder returns. Volatility often reflects cyclical businesses or share-count changes.
Check the drivers behind EPS
Analyze revenue growth, margin expansion, and buybacks to see which levers are powering EPS gains.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Gross Margin
61.3%
Operating Margin
15.7%
Net Profit Margin
11.1%
Return on Equity
8.5%
Return on Assets
4.7%
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Boston Scientific Corporation (BSX) FAQs
Answers tailored to Boston Scientific Corporation’s eps growth profile using the latest Financial Modeling Prep data.
What is Boston Scientific Corporation's current eps growth?
As of Dec 2024, Boston Scientific Corporation reports eps growth of 16.6%. This reading reflects the latest filings and price data for BSX.
How is Boston Scientific Corporation's eps growth trending year over year?
Year-over-year, the figure shifts by −124.1 pts (−88.2%). Pair this context with revenue growth and free cash flow signals to gauge momentum for BSX.
Why does eps growth matter for Boston Scientific Corporation?
Earnings-per-share growth reveals how quickly per-share net income is expanding or contracting versus the prior year. For Boston Scientific Corporation, operating within Healthcare — Medical - Devices, tracking this metric helps benchmark management's execution against close competitors.
Is Boston Scientific Corporation's eps growth above its recent average?
Boston Scientific Corporation's rolling three-period average sits at 40.7%. Comparing the latest reading of 16.6% to that baseline highlights whether momentum is building or fading for BSX.
How frequently is Boston Scientific Corporation's eps growth refreshed?
Data for BSX was last refreshed on Dec 18, 2025, 5:29 AM and updates automatically every 24 hours, keeping your valuation inputs current.